Chemed files Form 144 for planned sale of 942 common shares

Chemed filed a notice of proposed sale under Rule 144 covering 942 shares of its common stock.

Accepted by SEC EDGAR 12/11/2025 - 12:22 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Chemed filed a notice of proposed sale under Rule 144 covering 942 shares of its common stock. These shares are planned to be sold through UBS Financial Services Inc. on the NYSE, with an approximate sale date of 12/11/2025 and an aggregate market value of 405,645. The filing notes that 14,164,195 shares of common stock were outstanding, giving context for the size of this planned transaction. The seller acquired the 942 shares in a private transaction from Chemed on 12/01/2025 and paid for them on the same date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Chemed (CHE) shares are covered by this Form 144 notice?

The Form 144 notice covers 942 shares of Chemed common stock proposed to be sold.

What is the aggregate market value of the Chemed (CHE) shares to be sold?

The aggregate market value of the 942 Chemed shares covered by the notice is 405,645.

On which exchange are the Chemed (CHE) shares expected to be sold?

The 942 Chemed common shares are expected to be sold on the NYSE.

Who is the broker for the Chemed (CHE) Form 144 sale?

The proposed sale will be handled by UBS Financial Services Inc., located in Weehawken, NJ.

When were the Chemed (CHE) shares acquired that are being registered on Form 144?

The 942 shares of Chemed common stock were acquired on 12/01/2025 in a private transaction from Chemed.

How many Chemed (CHE) shares were outstanding at the time referenced in the notice?

The notice states that 14,164,195 shares of Chemed common stock were outstanding, providing a baseline for the company’s share count.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001676780
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Chemed
SEC File Number	001-08351
Address of Issuer	255 E 5th St #2609 Cincinnati OHIO 45202
Phone	5137626690
Name of Person for Whose Account the Securities are To Be Sold	Nicholas Westfall
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	former officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	942	405645	14164195	12/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common stock	12/01/2025	private transaction	Chemed			942	12/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	12/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Nicholas Westfall
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)